الولايات المتحدة · منصات وبيانات · MarketBeat

vTv Therapeutics Highlights Cadisegliatin’s Phase III Push to Tackle Type 1 Hypoglycemia

نشره MarketBeat · الولايات المتحدة منذ 1 س

vTv Therapeutics (NASDAQ:VTVT) used a virtual key opinion leader event to outline the continuing burden of hypoglycemia in type 1 diabetes, present patient and physician…

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

The Motley Fool

Oracle Calls Force Majeure Already?

MarketWatch

Bull markets tend to peak with a whimper, not a bang — but a 15% correction for the S&P 500 may be next

Seeking Alpha

Oil prices end lower in volatile session amid reports of U.S.-Iran diplomacy

Investing.com

NextDC shares plunge 42% to a near nine-year low after outlook cut

Yahoo Finance

Fifth Third Bancorp (FITB) Posted Strong Q3 2026 Earnings After Its Largest Conversion

Morningstar